Filter articles using the following links

JP Morgan 34th Annual Healthcare Conference, San Francisco (CA), US

AAO, November 14-17, 2015, Las Vegas (CA), US

BioEurope, November 2-4, 2015, Munich, Germany

ESGCT, September 17-20, 2015, Helsinki, Finland

GenSight Biologics Receives IND Acceptance from FDA to Enter Phase III with GS010

GenSight Biologics Closes $36 Million Series B Preferred Stock Financing

ISOPT, July 9-12, 2015, Berlin, Germany

GenSight Biologics Appoints Thomas Gidoin as Chief Financial Officer & Michael Wyzga to Board of Directors

EUNOS, 21-24 June, 2015, Ljubljana, Slovenia

BIO, June 15-17, 2015, Philadelphia (PA)